MIRANDA WOODWARD: Open Payments
NPI 1871320010 · CRANBERRY TWP, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,774 in 92 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $138 · 2025 $1,774
Food & beverage: $1,774
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $297 |
| Novo Nordisk Inc | 10 | $216 |
| AstraZeneca Pharmaceuticals LP | 9 | $208 |
| SHIELD THERAPEUTICS INC | 5 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $91 |
| Amgen Inc. | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Lilly USA, LLC | 4 | $72 |
| CSL Behring | 3 | $62 |
Products named: AIRSUPRA, UBRELVY, QULIPTA, ACCRUFER, JARDIANCE, Wegovy, FARXIGA, Auvelity.
Industry payments across PA — which companies pay providers there.
